Skip to content
Graphic of a grey and white triangle
Graphic of a grey and white triangle

Intellectual Property Disputes

Allen & Overy is well known for its precedent-setting intellectual property disputes advice. We represent clients worldwide, at the highest level, in the many different courts and tribunals key to IP matters.

A&O’s global IP team understands how to exploit the procedural and tactical possibilities that different forums offer, coordinating regional and global litigation and settlement strategies to achieve the right business outcomes for clients.

A firm technical understanding of underlying IP assets is crucial. Many of our team members have technical backgrounds and industry experience to advise with confidence in cases involving the most complex science and technology.

Antitrust issues and arbitration considerations are also increasingly important in IP disputes: we work with our top-tier antitrust and arbitration practices to deliver a seamless service.

Our multi-jurisdictional litigation experience covers all areas of IP, including:

  • Major patent litigation, including in the life sciences and technology sectors
  • Trade mark litigation at all levels
  • Trade secrets litigation, particularly in the finance and telecoms fields
  • Design and copyright litigation, often with an emphasis on digital rights

Our experience

Regeneron

Regeneron

on its European patent strategy for proprietary transgenic mouse technology (marketed as VelocImmune®) – the largest mammalian genetic engineering project ever completed.

Archos

Archos

in a multinational patent dispute concerning both standard essential patents and implementation patents relating to mobiles.

McDonald’s

McDonald’s

on a claim in relation to the McDonald’s “I’m Lovin’ It” jingle, song and trade mark where we advised three McDonald’s companies, as well as EMI, Pharrell Williams and Sony.

Intel

Intel

in litigation relating to its flagship Intel and Intel Inside trade marks (resulting in a number of changes in corporate names and trade names of third parties).

News and insights

Scientist using a microscopic lens

Publications: 10 June 2022

Webinar: Creating cross-border value with patent term extensions and supplementary protection certificates

The selection of a patent for Patent Term Extension (PTE) or Supplementary Protection Certification (SPC) exclusivities is a critical decision for new drug products.

Read more
blister pack of pills

Publications: 09 June 2022

Webinar: "Reverse Payments" from Actavis to California AB 824: The Current State of Litigation Settlements in the Hatch-Waxman/BCPIA Space

Since the Supreme Court’s seminal decision in Actavis, brand and generic drug companies have been working within the antitrust framework laid out in that decision to craft patent litigation…

Read more
server room

Publications: 09 June 2022

Taiwan Insights webinar: Global trade secret protection - what Taiwan businesses need to know

Trade secrets continue to be a critical challenge for Taiwanese businesses as global competition and tech innovation continues to grow. 

Read more
Liquid dropping into pharmaceutical test tubes

Publications: 09 June 2022

Excessive pricing and orphan drugs: Leadiant sanctioned by the Italian Antitrust Authority

The Italian Antitrust Authority has recently decided that Leadiant infringed Article 102 TFEU through a multifaceted strategy that led to it obtaining an excessive price for its CDCA Leadiant®…

Read more

Recognition of our work

Related content